Using quantitative susceptibility mapping and diffusion magnetic resonance imaging to identify structural features of early-stage Parkinson’s disease
Objective: To identify an imaging diagnostic biomarker of PD for use in clinics by applying structural magnetic resonance imaging (MRI) techniques. Background: The midbrain dopaminergic…Women with Parkinson’s Disease (PD) and High Coffee Use Have a Shorter Time to Medication Initiation
Objective: Investigate how coffee use prior to PD diagnosis affects medication initiation in PD. Background: Population studies show a decreased incidence of PD for men…Risk and Protective Substances among the Parkinson Disease Patients in Palembang Municipality
Objective: The aim of the study was to describe risks and protective consumptions and habits among the Parkinson's Disease (PD) Patients in Palembang Municipality Background:…Open-Label, Single-Arm, Exploratory Trial of Opicapone: Status Update of the OASIS (OPICAPONE IN SLEEP DISORDER) Study
Objective: This study aims to evaluate the effects of opicapone (OPC) 50 mg treatment on sleep disorders in patients with Parkinson’s disease (PD) and ‘wearing-off’.…The use of artificial intelligence-based chatbot in Parkinson’s disease
Objective: This study aimed to assess the feasibility and efficacy of using an artificial intelligence-based chatbot for smile and speech in Parkinson’s disease (PD). Further,…The role of GBA1 mutations in the relationship between GBA1 and alpha-synuclein in Parkinson disease
Objective: The aim of the study was to understand how the E326K GBA1 mutation results in an increased risk for Parkinson disease, through influencing the…The STEPWISE Parkinson study: a Smartphone Based Exercise Solution for Patients With Parkinson’s Disease
Objective: To investigate the feasibility of a smartphone app (STEPWISE app) to increase the physical activity level (i.e. number of steps) in people with Parkinson’s…Understanding patient perceptions of the key components of Medication Adherence in PD: a multicenter, international study
Objective: To understand how patients with Parkinson's disease (PD) and their care partners describe medication adherence. Background: Medication adherence in is a complex construct, associated…The Complexity of Parkinson Disease Medication Regimens May Factor into Treatment Decisions: Results of a PMD Alliance Survey
Objective: Identify factors affecting PwPD and CP communications with HCPs regarding dyskinesia and OFF episodes. Background: Managing Parkinson Disease (PD) requires clear and open communication…Environmental factors and Parkinson’s disease
Objective: To assess environmental factors in the development and protection of Parkinson's disease. Background: The cause of Parkinson's disease is not known, but in summarizing…
- « Previous Page
- 1
- …
- 304
- 305
- 306
- 307
- 308
- …
- 436
- Next Page »